10,000 Shares in HealthEquity, Inc. (NASDAQ:HQY) Purchased by Rockport Wealth LLC

Rockport Wealth LLC acquired a new stake in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 10,000 shares of the company's stock, valued at approximately $960,000. HealthEquity makes up about 0.4% of Rockport Wealth LLC's holdings, making the stock its 28th largest holding.

A number of other hedge funds also recently bought and sold shares of HQY. Arcadia Investment Management Corp MI purchased a new position in shares of HealthEquity in the fourth quarter worth $26,000. Smartleaf Asset Management LLC raised its holdings in HealthEquity by 34.3% during the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock valued at $37,000 after buying an additional 98 shares during the last quarter. UMB Bank n.a. raised its holdings in HealthEquity by 65.6% during the 4th quarter. UMB Bank n.a. now owns 414 shares of the company's stock valued at $40,000 after buying an additional 164 shares during the last quarter. Skandinaviska Enskilda Banken AB publ raised its holdings in HealthEquity by 1,934.8% during the 4th quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company's stock valued at $45,000 after buying an additional 445 shares during the last quarter. Finally, Lindbrook Capital LLC raised its holdings in HealthEquity by 27.6% during the 4th quarter. Lindbrook Capital LLC now owns 750 shares of the company's stock valued at $72,000 after buying an additional 162 shares during the last quarter. Institutional investors own 99.55% of the company's stock.

HealthEquity Stock Up 0.3 %

NASDAQ HQY traded up $0.28 during midday trading on Thursday, hitting $84.60. 2,370,590 shares of the company traded hands, compared to its average volume of 691,476. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. The company has a market cap of $7.33 billion, a PE ratio of 77.61, a price-to-earnings-growth ratio of 1.60 and a beta of 0.62. The company's 50-day simple moving average is $105.51 and its 200-day simple moving average is $95.59. HealthEquity, Inc. has a 52 week low of $65.01 and a 52 week high of $115.59.

Remove Ads

Insider Activity

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the transaction, the director now owns 78,219 shares in the company, valued at approximately $8,704,992.51. This trade represents a 6.85 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 2.20% of the company's stock.

Wall Street Analysts Forecast Growth

HQY has been the subject of a number of recent analyst reports. Wells Fargo & Company upped their price target on shares of HealthEquity from $110.00 to $125.00 and gave the company an "overweight" rating in a report on Wednesday, February 26th. JMP Securities upped their price objective on shares of HealthEquity from $105.00 to $107.00 and gave the stock a "market outperform" rating in a report on Tuesday, December 10th. Barrington Research restated an "outperform" rating and issued a $112.00 price objective on shares of HealthEquity in a report on Friday, March 14th. Mizuho began coverage on shares of HealthEquity in a report on Wednesday, December 4th. They issued an "outperform" rating and a $126.00 price objective for the company. Finally, Raymond James upped their price objective on shares of HealthEquity from $105.00 to $120.00 and gave the stock an "outperform" rating in a report on Tuesday, February 25th. One analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $112.92.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.